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Abstract
Background: Nausea and vomiting are experienced by most women during pregnancy. The onset is usually related
to Last Menstrual Period (LMP) the date of which is often unreliable. This study describes the time to onset of nausea
and vomiting symptoms from date of ovulation and compares this to date of last menstrual period
Methods: Prospective cohort of women seeking to become pregnant, recruited from 12 May 2014 to 25 November
2016, in the United Kingdom. Daily diaries of nausea and vomiting were kept by 256 women who were trying to
conceive. The main outcome measure is the number of days from last menstrual period (LMP) or luteinising hormone
surge until onset of nausea or vomiting.
Results: Almost all women (88%) had Human Chorionic Gonadotrophin rise within 8 to 10 days of ovulation; the
equivalent interval from LMP was 20 to 30 days. Many (67%) women experience symptoms within 11 to 20 days of
ovulation.
Conclusions: Onset of nausea and vomiting occurs earlier than previously reported and there is a narrow window for
onset of symptoms. This indicates that its etiology is associated with a specific developmental stage at the
foetal-maternal interface.
Trial registration: NCT01577147. Date of registration 13 April 2012
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Background
Nausea and vomiting of pregnancy (NVP) has been recog-
nised as a feature of early pregnancy for well over 2000
years. Hippocrates who lived from 460 to 370 BC wrote
“when a woman who is suffering from neither rigours nor
fever, develops amenorrhea and is liable to nausea, she is
pregnant” [1]. Different national guidelines recommend
different approaches to the management of NVP, with a
wide range of recommendations [2].
The precise date and the characteristics of its onset have
been more difficult to define. Several papers that describe
onset [3, 4] have collected data retrospectively by ask-
ing women to describe their onset when they attend their
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first ante-natal clinic often at around 12 weeks from last
menstrual period (LMP). Such retrospective data may be
particularly unreliable if symptoms are mild and have sub-
sided by the time of data collection. In the Canadian study,
74% of women reported nausea [4]. A study describing
the onset and natural history of NVP that asked women
to present when they first thought they were pregnant so
as to enter the study as early as possible in order to col-
lect symptoms prospectively, reported entry at a median
of day 57 from LMP. In that study 58 (16%) of women out
of a study population of 363 reported symptoms before
entry, some of them up to 14 days before entry [5]. Using
LMP to date onset of pregnancy nausea and vomiting may
also be problematic. Some studies have shown that only
32% of women were certain of the date of their LMP [6].
A higher incidence of round number preferences were
recorded when women were asked the date of their LMP
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with the 15th of the month given 2.5 times more often
than expected [7].
A much more accurate way of dating a pregnancy is
from using the date of ovulation which can be deter-
mined by measuring the surge in luteinising hormone
(LH) that stimulates ovulation [8]. The cause of NVP is
still largely unknown, but is thought to be multifactorial,
with a genetic element in its aetiology [9]. A psychiatric
aetiology has been proposed in the past but, although this
has been disproven [10], sufferers feel that this remains an
inhibitor to the empathy and care the condition deserves
[10]. Women who have experienced severe NVP are very
keen to stress the biological nature of the condition [11].
Evidence that there is a very close association between
the onset of NVP symptoms and the onset of pregnancy,
as measured from the date of ovulation, would provide
further evidence for a biological aetiology.
In this paper we study the onset of NVP in relation to
the date of ovulation and LMP
Methods
A cohort study conducted by SPD Development Com-
pany Limited (SPD) was originally designed to investigate
hormone levels in early pregnancy. It was extended to
include the study of pregnancy sickness and vomiting; the
methodology has described previously [12]. In brief, the
study was registered (NCT01577147) and ran from 15
May 2014 to 17 February 2017. Volunteers were recruited
preconception, and all gave written consent for the home-
based study. Inclusion criteria were: at least 18 years old
and seeking to become pregnant and has regular men-
strual periods. Exclusion criteria were: medical conditions
that contra-indicate pregnancy, known infertility or hav-
ing treatment for infertility or women who were currently
pregnant.
Volunteer demographics, menstrual cycle information
and previous pregnancy history were collected at admis-
sion. From day 1 of their next menstrual cycle, volunteers
collected a daily early morning urine sample and com-
pleted a daily diary. Lutenising hormone (LH) was mea-
sured (AutoDELFIA, Perkin Elmer) in order to determine
the day of LH surge, which precedes ovulation by approx-
imately 1 day. Human Chorionic Gonadotrophin (hCG)
was measured (AutoDELFIA, Perkin Elmer) in late luteal
phase and throughout early pregnancy, in order to identify
viable pregnancy and early pregnancy loss.
Home pregnancy tests were provided to volunteers.
When a volunteer reported pregnancy to the study site,
she was instructed to record each hour of nausea and
vomiting symptoms in a diary. The questionnaire was
adapted from the PUQE score system for recording nau-
sea and vomiting to allow more details of times (Supple-
mentary material 1: Diary). The instructions were to start
recording on day 30 following LMP (date of last menstrual
period), and stop at day 60 from LMP. Hence participants
started the diaries on different days of their pregnancy.
Womanwho did not achieve pregnancy were instructed to
collect urine samples and complete symptom diaries only
up to day 7 of her next cycle.
Statistical methods
The anonymised dataset was transferred to the Depart-
ment of Statistics at the University of Warwick and exam-
ined by Master’s students using R Studio statistical Soft-
ware. Standard summary statistics, linear regression and
significance tests were used. For the table, age and hours
per day of symptoms were split approximately into thirds,
and body mass index (BMI, kg/m2) into normal, over-
weight and obese categories. For investigation of time to
onset of symptoms by age and BMI, the variables were
continuous. A NVP score was calculated as the average
daily hours of nausea and vomiting based on the time
period the women reported, using available data. A high
level summary of symptom severity is given; results for
diurnal variation are given elsewhere [12].
Results
Study population
Initially, 1443 women who were planning to become preg-
nant were recruited into the study. 1073 of those women
did not achieve pregnancy in a one-month period, 17
women had a miscarriage and 65 women had early losses.
Out of the remaining 288, who successfully conceived, 32
dropped out of the study. Hence, the study population
includes 256 women. Only 866 samples of the expected
16830 urine samples were missing from the daily sample
collections, providing 95% coverage.
Many, 60%, of the women had previously had live births,
mainly one child (Table 1, Total column). The mean age
was 30.4 years, the mean age of mothers in England and
Wales in 2016 [13]; age ranged from 18 to 43. The major-
ity (54%) of younger women (< 28) in the study had
no children, and half of women over 32 had one child.
Most (95%) of the women were white and were Euro-
pean. The mean BMI was 27.0 kg/m2, standard deviation
6.1 kg/m2. Half (53%) the women were overweight or
obese, and 9% were underweight; one BMI was missing.
Almost half (43%) of the population had previously suf-
fered at least one miscarriage, with more miscarriages
associated with more live births. Most participants (75%)
had an education level of A-levels or higher, and more of
these women (43%) had no previous live births, although
those with degrees were older than those without A-
levels. Before conceiving during this study, volunteers had
been trying for a mean of 8.42 months, median of 5
months.
Daily diaries
Only 10 women had any missing daily symptom diaries;
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Table 1 Characteristics of 256 women in nausea and vomiting diary study
Characteristic Average hours per day Nausea and Vomiting Totals
< 1, 5 hours/day (1.5,4] hours/day ≥ 4 hours/day
All women 56 (22%) 108 (42%) 92 (36%) 256 (100%)
Age
18-28 20 (24%) 40 (48%) 24 (29%) 84 (33%)
29-32 22 (23%) 44 (45%) 31 (32%) 97 (38%)
33-43 14 (19%) 24 (32%) 37 (49%) 75 (29%)
BMI
≤ 25kg/m2 32 (27%) 53 (45%) 34 (29%) 119 (46%)
(25,30] kg/m2 18 (24%) 30 (32%) 28 (44%) 63 (25%)
> 30 kg/m2 8 (11%) 34 (47%) 30 (42%) 72 (28%)
Smoking
Current or ex 37 (24%) 54 (35%) 42 (42%) 100 (39%)
Never 19 (19%) 54 (54%) 27 (47%) 156 (61%)
Previous live births
0 28 (27%) 52 (50%) 23 (22%) 100 (40%)
1 21 (20%) 39 (37%) 45 (43%) 105 (41%)
≥ 2 7 (15%) 17 (35%) 24 (50%) 48 (19%)
Miscarriages
0 35 (24%) 60 (41%) 50 (34%) 145 (57%)
1 12 (18%) 35 (51%) 21 (31%) 68 (27%)
≥ 2 9 (21%) 13 (30%) 21 (49%) 43 (17%)
Education level
Below A-level 11 (17%) 35 (56%) 17 (27%) 63 (25%)
A-levels 16 (19%) 32 (38%) 36 (43%) 84 (33%)
Degree level 29 (27%) 41 (38%) 39 (36%) 109 (43%)
9 missed a single day and one missed three days. As this
is negligible, the overall NVP scores for each women used
available data. 61% (n = 148) of the volunteers with NVP
started filling in their daily diaries before they had their
first symptoms. The remaining 93 participants first filled
in their daily diaries on the first day they experienced
symptoms. Their mean onset was a week earlier than
those who started diaries before first symptoms, so there
is no reason to believe symptoms occured before the first
recorded day.
Most women, 94.1% (n= 241) had some symptoms of
NVP. In particular, 35% (n = 89) of the women experi-
enced just nausea, 59% (n= 150) suffered from both nausea
and vomiting. Two volunteers reported to have had only
vomiting, however the intensity was respectively 1 hour
and 4 hours of sickness (vomiting) throughout their whole
pregnancies. Women with more than one previous live
births experience significantly longer average hours of
symptoms per day, median 3.9 hours.
LMP vs. ovulation
By convention and in all relevant to NVP literature, LMP
is considered as the beginning of pregnancy. Nevertheless,
this is somewhat inaccurate as for women with monthly
cycles of different lengths, the time between LMP and
ovulation and hence between LMP and fertility or impreg-
nation varies. Nevertheless, as the ovulation day can be
calculated by the LH surge, it was included in this data
set. The inclusion of both of these dates in the data set
allows for a comparison of their accuracy as a measure
of the start of pregnancy. As the concentration of hCG
is an ideal marker of pregnancy [8], comparing the dates
of LMP and ovulation to the first date when the preg-
nancy hormone hCG first reached a concentration of 1
mIU/ml (the hCG rise) can be expected to give an accurate
result of the comparison. Figure 1 compares the duration
to start of pregnancy. Almost all women (88%) had hCG
rise within 8 to 10 days of ovulation. Only 3% had inter-
vals less than 8 days, and 9% more than 10 days. The time
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Days from LMP and ovulation to hCG > 1mlU/ml


















Fig. 1 Days from LMP and from Ovulation day to hCG >1mlU/ml (256 women)
between LMP and the hCG rise varies significantly more,
with 88% within 20 days to 30 days (11 days as opposed to
3 days), and 9% 31 to 60 days (Table 2). This demonstrates
that the day of ovulation, calculated by the LH surge, is
a much more precise indicator of the start of pregnancy
than the first day of the last menstrual period.
Onset of symptoms
From ovulation, symptoms start approximately two weeks
earlier, and aremore concentrated than from LMP (Fig. 2).
Two-thirds of women have onset within 11 to 20 days
from ovulation day, and only 5% have earlier onset. The
median from ovulation to symptom onset is 16 days and
from LMP is 32 days. For onset from LMP, 67% have onset
within 26 to day 40 (Fig. 2), with highest frequency at 28
days after LMP. Again, precision is greater when measur-
ing pregnancy from ovulation (Table 2). Symptoms start
slightly earlier for women with higher BMI values (Fig. 3),
by about one day for an increase of 5 kg/m2 (regression
coefficient -0.225, standard error 0.075). Predicted onset
is day 20 for a woman with BMI 18 kg/m2 and day 16
for a woman with BMI 35 kg/m2. Symptoms start slightly
later with increasing age (Fig. 3), by almost one day for an
increase of 3 years (regression coefficient 0.295, standard
error 0.094). Predicted onset is day 14 for an 18 year old,
and day 21 for a 41 year old woman.
Symptoms disappeared by week 7 from LMP for 20
(8%) of the volunteers, 11 of whom never vomited and 16
of whom had symptoms less than 2 hours per day. Fur-
thermore, out of the 25 women whose symptoms ended
in week 8 of their pregnancies, 15 had symptoms less
than 2 hours per day. These 32-35 women (12-14% of the
study population) with early ormild symptomsmight have
not recorded them if they were first asked about their
symptoms at a later stage of their pregnancy.
Severity of symptoms
Table (1) provides a high level summary of symptom
Table 2 Times to hCG rise (256 women) and to onset of symptoms (241 women)
Time Summary statistics in days
Minimum Lower Median Upper Maximum
quartile quartile
LMP to hCG >1mlU/ml 15 23 25 28 60
Ovulation to hCG >1mlU/ml 1 9 9 10 13
LMP to symptom onset 21 28 32 40 66
Ovulation to symptom onset 8 13 16 22 45
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Fig. 2 Distribution of onset of symptoms from LMP and from Ovulation (214 women)
severity considered as average hours per day. A fifth (22%)
of women hadminimal nausea and vomiting, with an aver-
age of less than an hour per day; 36% averaged more than
4 hours per day. Smokers and those with at least two pre-
vious live births tended to have symptoms for longer each
day. There is no simple association with miscarriages, and
a slight suggestion of lower symptom rates for women
with degree level education.
Discussion
Main findings
This paper describes for the first time the onset of symp-
toms of nausea and vomiting in pregnancy from the day
of ovulation. The vast majority of women (94%) experi-
enced symptoms which started within a clear, narrow time
window from ovulation. In particular, symptoms began
between days 11 and 20 for 67% (n = 160) of the 241 par-


































Fig. 3 Onset of symptoms from ovulation: association with age and body mass index (BMI), 214 women
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ticipants withNVP.When LMP is used to date the onset of
pregnancy, as has been done in previously published stud-
ies, the equivalent range is days 26 to 40. Onset was later
with increasing age, and slightly earlier with increasing
BMI. The close connection between onset of NVP symp-
toms and date of ovulation reinforces the theory that the
aetiology of the condition is biological, rather than psy-
chiatric, and is based on the emerging physiology at the
foetal-maternal interface.
Interpretation
Onset of symptoms of nausea or vomiting was earlier than
reported in other articles: median from LMP at day 32,
compared to day 57, 8 weeks [5] or 5 weeks [4]. A possible
reason for this discrepancy is that the volunteers in this
study were all women who have been trying to get preg-
nant for a while and would be awaiting early mild NVP
symptoms as one of the first signs they were pregnant.
Moreover, in all of the studies mentioned above the initial
interview or survey was at least 8-9 weeks after onset. In
this setting some of the participants who had experienced
brief symptoms in the beginning of their pregnancies
might have forgotten about them when they had to report
their experiences of symptoms retrospectively, [14].
The prevalence of NVP symptoms in this study, at 94%,
is higher than that reported in other studies, which have
reported a prevalence of NVP symptoms in 50-80% of
pregnant women [4, 5]. In a literature review that included
data from 26 published papers, of 39710 pregnancies, the
percentage of pregnant women experiencing NVP symp-
toms was 73.4% [15]. A meta-analysis of 59 studies of
NVP (93,753 women) reported a median rate of 69%,
range 35% to 91%; rates for East Asian countries were
between 75% and 91% [16]. Prevalence estimates from
clinical records of NVP are much lower 9.1% [17]. Again,
one reason may be that the women were actively try-
ing to conceive and this might have made them more
inclined to notice details related to their pregnancies such
as mild symptoms. Another reason could be that most
previous studies of NVP onset recorded at least some of
their data retrospectively. Mild early symptoms of NVP
may get overlooked and forgotten, especially if women
are being asked to remember them a number of weeks
later. Detailed results for factors affecting symptoms are a
separate article.
This hypothesis was confirmed in this study in that 13%
(n=32) of women who had very early symptoms up to
week 7 or mild symptoms, lost them by day 56 (week 8)
from LMP, the date at which many previous studies began
their prospective recording of NVP symptoms. The mean
day of onset of NVP symptoms in this study is day 18
from ovulation, while from LMP it is day 34. This date
from LMP is slightly earlier than 39 days [5] or 40 days
(5.7 weeks) [4] reported previously. In a review of onset
of NVP symptoms from LMP, data from 7 papers with a
pooled population of 2092 women, had mean day of onset
from LMP as day 39 [15].
Strengths and limitations
The strengths of our study are that it is based on a siz-
able cohort of women who are broadly representative of
women planning to become pregnant in the UK. The data
on NVP symptoms was collected prospectively from the
onset of pregnancy and we can pinpoint the day of ovu-
lation through the measurement of the LH surge. As the
mean onset of NVP for those who started their preg-
nancy diaries on the first day of symptoms was a week
earlier than those who started diaries before first symp-
toms, it is likely that symptoms did not occur before
the first recorded day. Some weaknesses of the study
are that the dataset under-represents women from lower
socio-economic (educational) backgrounds, and black and
minority ethnic backgrounds. Unplanned pregancies were
not included, but there is no evidence of difference in NVP
for planned or unplanned pregnancies. East Asian coun-
tries report higher prevalence of NVP [16] but onset is
not addressed. These results could be generalisable across
education backgrounds for developed countries. Women
in the study stopped recording NVP symptoms at around
week 9 of pregnancy when several of them were still expe-
riencing symptoms so that this dataset cannot be used to
reliably describe NVP symptom cessation.
Conclusion
Onset of NVP occurs earlier than previously reported
and there is a narrow window for onset of symptoms
from ovulation. This indicates that its etiology is associ-
ated with a specific developmental stage. Further study of
the association between levels of hCG in urine and NVP
symptoms could help to indicatemore effective treatment.
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